Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes

被引:105
|
作者
Canki, M
Thai, JNF
Chao, W
Ghorpade, A
Potash, MJ
Volsky, DJ [1 ]
机构
[1] St Lukes Roosevelt Hosp, Div Mol Virol, 432 W 58th St,Antenucci Res Bldg,Rm 709, New York, NY 10019 USA
[2] Columbia Univ, New York, NY 10019 USA
[3] Univ Nebraska, Med Ctr, Ctr Neurovirol & Neurodegenerat Disorders, Omaha, NE 68198 USA
关键词
D O I
10.1128/JVI.75.17.7925-7933.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human astrocytes can be infected with human immunodeficiency virus type I (HIV-1) in vitro and in vivo, but, in contrast to T lymphocytes and macrophages, virus expression is inefficient. To investigate the HIV-1 life cycle in human fetal astrocytes, we infected cells with HIV-1 pseudotyped with envelope glycoproteins of either amphotropic murine leukemia virus or vesicular stomatitis virus. Infection by both pseudotypes was productive and long lasting and reached a peak of 68% infected cells and 1.7 mug of viral p24 per ml of culture supernatant 7 days after virus inoculation and then continued with gradually declining levels of virus expression through 7 weeks of follow-up. This contrasted with less than 0.1% HIV-1 antigen-positive cells and 400 pg of extracellular p24 per ml at the peak of astrocyte infection with native HIV-1. Cell viability and growth kinetics were similar in infected and control cells. Northern blot analysis revealed the presence of major HIV-1 RNA species of 9, 4, and 2 kb in astrocytes exposed to pseudotyped (but not wild-type) HIV-1 at 2, 14, and 28 days after infection. Consistent with productive infection, the 9- and 4-kb viral transcripts in astrocytes infected by pseudotyped HIV-1 were as abundant as the 2-kb mRNA during 4 weeks of follow-up, and both structural and regulatory viral proteins were detected in infected cells by immunoblotting or cell staining. The progeny virus released by these cells was infectious. These results indicate that the major barrier to HIV-1 infection of primary astrocytes is at virus entry and that astrocytes have no intrinsic intracellular restriction to efficient HIV-1 replication.
引用
收藏
页码:7925 / 7933
页数:9
相关论文
共 50 条
  • [1] Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 gag vaccination
    Balamurugan, Arumugam
    Lewis, Martha J.
    Kitchen, Christina M. R.
    Robertson, Michael N.
    Shiver, John W.
    Daar, Eric S.
    Pitt, Jacqueline
    Ali, Ayub
    Ng, Hwee L.
    Currier, Judith S.
    Yang, Otto O.
    JOURNAL OF VIROLOGY, 2008, 82 (06) : 2784 - 2791
  • [2] Hepatic encephalopathy in primary human immunodeficiency virus type 1 (HIV-1) infection
    Kobessho, H
    Matsushita, A
    Takahashi, K
    Shimodaira, M
    Ishihara, T
    Oita, T
    Takahashi, T
    INTERNAL MEDICINE, 2002, 41 (11) : 1069 - 1072
  • [3] Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection
    Rieder, Philip
    Joos, Beda
    Scherrer, Alexandra U.
    Kuster, Herbert
    Braun, Dominique
    Grube, Christina
    Niederoest, Barbara
    Leemann, Christine
    Gianella, Sara
    Metzner, Karin J.
    Boeni, Juerg
    Weber, Rainer
    Guenthard, Huldrych F.
    CLINICAL INFECTIOUS DISEASES, 2011, 53 (12) : 1271 - 1279
  • [4] PRODUCTIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION OF NONPROLIFERATING HUMAN MONOCYTES
    WEINBERG, JB
    MATTHEWS, TJ
    CULLEN, BR
    MALIM, MH
    JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06): : 1477 - 1482
  • [5] MYOPATHY WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION - HIV-1 OR ZIDOVUDINE
    TILL, M
    MACDONELL, KB
    ANNALS OF INTERNAL MEDICINE, 1990, 113 (07) : 492 - 494
  • [6] Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infection
    Sei, S
    Sandelli, SL
    Theofan, G
    Ratto-Kim, S
    Kumagai, M
    Loomis-Price, LD
    Cox, JH
    Jarosinski, P
    Walsek, CM
    Brouwers, P
    Venzon, DJ
    Xu, J
    Pizzo, PA
    Moss, RB
    Robb, ML
    Wood, LV
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (03): : 626 - 640
  • [7] An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication
    An, DS
    Morizono, K
    Li, QX
    Mao, SH
    Lu, S
    Chen, ISY
    JOURNAL OF VIROLOGY, 1999, 73 (09) : 7671 - 7677
  • [8] PRODUCTIVE HIV-1 INFECTION OF PRIMARY HUMAN NEUROBLASTS
    ENSOLI, F
    ENSOLI, B
    CAFARO, A
    VANELLI, GB
    GALLO, C
    PIZZO, PA
    THIELE, CJ
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S79 - S79
  • [9] Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis
    Nukuna A.
    Gendelman H.E.
    Limoges J.
    Rasmussen J.
    Poluektova L.
    Ghorpade A.
    Persidsky Y.
    Journal of NeuroVirology, 2004, 10 (Suppl 1) : 82 - 90
  • [10] Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis
    Nukuna, A
    Gendelman, HE
    Limoges, J
    Rasmussen, J
    Poluektova, L
    Ghorpade, A
    Persidsky, Y
    JOURNAL OF NEUROVIROLOGY, 2004, 10 : 82 - 90